Dr. Emily Leibovitch supports the firm's patent prosecution practice in the areas of biotechnology, medical devices, molecular biology, genetics, and life sciences. Dr. Leibovitch's research experience includes translational neuroimmunology, neurovirology, molecular biology, and vaccines.
Dr. Leibovitch received her PhD in Microbiology and Immunology in 2017 through a joint partnership program between the George Washington University School of Medicine and the National Institutes of Health (NIH). Her graduate research involved preclinical studies of herpesviruses associated with neurologic diseases, for which she was awarded a Dimitris N. Chorafas Prize.
Before joining the firm, Dr. Leibovitch completed a Post-Doctoral Fellowship at the NIH, during which she continued to study mechanisms of viruses in neurologic diseases. During this time, she also performed preclinical anti-viral vaccine studies, with a focus on T cell immunology.
She has authored many articles in journals including PLOS Pathogens and Proceedings of the National Academy of Sciences, and co-authored articles in Nature Communications, Brain, and Journal of Clinical Investigation.
- PhD, Microbiology and Immunology, The George Washington University, 2017
- BS, Biology, University of North Carolina at Chapel Hill, 2008, honors, Distinction in Biology
- *Not admitted to the practice of law